Bluebird Bio reported $-76513000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US USD 36.53M 118.27M
Alnylam Pharmaceuticals ALNY:US USD -207021000 122.34M
Amgen AMGN:US USD 2.54B 364M
Arrowhead Research ARWR:US USD -41794000 40.36M
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
Bluebird Bio BLUE:US USD -76513000 16.99M
Gilead Sciences GILD:US USD 2.52B 357M
Immunogen IMGN:US USD -57790000 19.96M
Intercept Pharmaceuticals ICPT:US USD -17543000 86.54M
Mirati Therapeutics MRTX:US USD -202221000 28.91M
Moderna Inc MRNA:US USD 1.66B 438M
Nektar Therapeutics NKTR:US USD -56544000 2.66M
Novartis NOVN:VX USD 3.86B 195M
Pfizer PFE:US USD 7.38B 3.3B
Ptc Therapeutics PTCT:US USD -156309000 29.1M
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Sangamo Biosciences SGMO:US USD -51714000 1.41M
Sarepta Therapeutics SRPT:US USD -101306000 155.11M
Ultragenyx Pharmaceutical RARE:US USD -153284000 85.54M
Vertex Pharmaceuticals VRTX:US USD 1.2B 122.8M
YTE INCY:US USD 178.62M 401K